TABLE 2.

Correlation of PLEK2 expression and clinical characteristics of UVM patients.

	[All]	High PLEK2 level	Low PLEK2 level	p-value overall
	N = 80	N = 40	N = 40
Age	61.6 (13.9)	60.0 (12.8)	63.4 (15.0)	0.278
Gender				0.652
Female	35 (43.8%)	16 (40.0%)	19 (47.5%)
Male	45 (56.2%)	24 (60.0%)	21 (52.5%)
person_neoplasm_cancer_status:				0.013
Tumor free	61 (77.2%)	25 (64.1%)	36 (90.0%)
With tumor	18 (22.8%)	14 (35.9%)	4 (10.0%)
new_tumor_events:				0.163
No	51 (63.7%)	22 (55.0%)	29 (72.5%)
Yes	29 (36.2%)	18 (45.0%)	11 (27.5%)
clinicial_stage:				0.090
Stage II	36 (45.0%)	15 (37.5%)	21 (52.5%)
Stage III	40 (50.0%)	21 (52.5%)	19 (47.5%)
Stage IV	4 (5.00%)	4 (10.0%)	0 (0.00%)
tumor_basal_diameter	16.9 (3.45)	17.7 (3.50)	16.1 (3.25)	0.039
tumor_thickness	10.4 (2.81)	10.3 (3.09)	10.5 (2.54)	0.708